The Effects of Frailty on Chronic Kidney Disease
Sarcopenia, Chronic Kidney Disease
About this trial
This is an interventional treatment trial for Sarcopenia
Eligibility Criteria
Inclusion Criteria:
- Chronic Kidney Disease Stage III to IV
- Receiving care at the San Francisco Veterans Affairs Medical Center
- Able to consent in English
Exclusion Criteria:
- Early chronic kidney disease
- individuals with acute kidney injury
- non-ambulatory
Sites / Locations
- Department of Veterans' Affairs Medical Center, San Francisco
Arms of the Study
Arm 1
Arm 2
No Intervention
Experimental
Not frail
Frail
Source of these participants will be the same as those who screen into the study; patients with chronic kidney disease receiving care at the San Francisco Veteran Affairs Medical Center. Based on initial screening if participants do not meet criteria for frailty, baseline screening data will be used for comparative analysis as the no intervention arm.
Source of these participants will be the same as those who screen into the study; patients with chronic kidney disease receiving care at the San Francisco Veteran Affairs Medical Center. Based on initial screening if participants meet criteria for frailty participants will be enrolled in the intervention arm. Participants who are ambulatory regardless of co-morbidities will not be excluded from the study.